E
Aspira Women's Health Inc. AWHL
OTC PK
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 55.07% 24.63% -52.35% 29.63% 32.72%
Total Depreciation and Amortization -62.16% -42.50% -50.00% -58.57% -46.38%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 246.88% -86.65% 38.34% -68.48% -7,033.33%
Change in Net Operating Assets -1,533.33% 246.79% 476.09% -90.53% 100.70%
Cash from Operations 70.41% 12.07% -9.48% 22.34% 51.24%
Capital Expenditure 100.00% -- -275.00% -150.00% 83.78%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 100.00% -- -275.00% -150.00% 83.78%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -194.74% 79.27% -- 100.00%
Issuance of Common Stock -9.51% -51.02% 405.05% 3,580.86% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -397.37% 422.18% -1,850.00% -425.76% -31.03%
Cash from Financing -31.63% -1.99% 679.85% 9,680.00% 1,122.34%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 85.45% 36.96% 17.52% 114.18% 65.47%